Neuren Pharmaceuticals Limited (ASX:NEU)
Australia flag Australia · Delayed Price · Currency is AUD
12.26
+0.25 (2.08%)
Mar 28, 2025, 4:10 PM AEST

Neuren Pharmaceuticals Income Statement

Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
213.24231.9314.55-0.72
Upgrade
Other Revenue
3.590.020.863.2-
Upgrade
Revenue
216.83231.9415.423.20.72
Upgrade
Revenue Growth (YoY)
-6.51%1404.46%382.23%345.89%44.85%
Upgrade
Cost of Revenue
32.9726.7512.719.527.76
Upgrade
Gross Profit
183.86205.192.71-6.32-7.05
Upgrade
Selling, General & Admin
4.75.953.441.911.76
Upgrade
Operating Expenses
4.75.953.441.911.76
Upgrade
Operating Income
179.16199.25-0.73-8.23-8.81
Upgrade
Interest & Investment Income
11.015.690.390.040.15
Upgrade
Currency Exchange Gain (Loss)
-7.242.431.230.4-0.63
Upgrade
Other Non Operating Income (Expenses)
--2.23-0.7-0.1
Upgrade
EBT Excluding Unusual Items
182.94205.140.18-7.79-9.19
Upgrade
Pretax Income
182.94205.140.18-7.79-9.19
Upgrade
Income Tax Expense
40.948.06---
Upgrade
Earnings From Continuing Operations
142.04157.080.18-7.79-9.19
Upgrade
Net Income
142.04157.080.18-7.79-9.19
Upgrade
Net Income to Common
142.04157.080.18-7.79-9.19
Upgrade
Net Income Growth
-9.57%85270.11%---
Upgrade
Shares Outstanding (Basic)
128127126118107
Upgrade
Shares Outstanding (Diluted)
131131129119107
Upgrade
Shares Change (YoY)
0.01%1.44%8.76%10.71%6.88%
Upgrade
EPS (Basic)
1.111.240.00-0.07-0.09
Upgrade
EPS (Diluted)
1.091.200.00-0.07-0.09
Upgrade
EPS Growth
-9.58%120020.00%---
Upgrade
Free Cash Flow
-11.28184.893.58-9.98-8.08
Upgrade
Free Cash Flow Per Share
-0.091.410.03-0.08-0.08
Upgrade
Gross Margin
84.80%88.47%17.55%-197.65%-
Upgrade
Operating Margin
82.63%85.90%-4.75%-257.52%-1228.59%
Upgrade
Profit Margin
65.51%67.72%1.19%-243.79%-1282.15%
Upgrade
Free Cash Flow Margin
-5.20%79.71%23.22%-312.17%-1127.48%
Upgrade
EBITDA
179.18199.26-0.72-8.23-8.8
Upgrade
EBITDA Margin
82.64%85.91%-4.68%-257.27%-
Upgrade
D&A For EBITDA
0.020.020.010.010.01
Upgrade
EBIT
179.16199.25-0.73-8.23-8.81
Upgrade
EBIT Margin
82.63%85.90%-4.75%-257.52%-
Upgrade
Effective Tax Rate
22.36%23.43%---
Upgrade
Revenue as Reported
227.85240.0617.033.640.96
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.